| Tyler Francis Aguinaldo, MD | |
|
1501 Trousdale Dr Fl 3, Burlingame, CA 94010-4506 | |
| (650) 652-8580 | |
| Not Available |
| Full Name | Tyler Francis Aguinaldo |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 25 Years |
| Location | 1501 Trousdale Dr Fl 3, Burlingame, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306811906 | NPI | - | NPPES |
| 00A735990 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | A73599 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Peninsula Medical Center | Burlingame, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sutter Bay Medical Foundation | 4284538778 | 2941 |
News Archive
Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and fibrotic organ failure, announced today that its lead clinical candidate STX-100 has been granted orphan drug status by the U.S. Food and Drug Administration for the treatment of idiopathic pulmonary fibrosis, a debilitating and almost uniformly fatal disease in which patients experience progressive difficulty breathing due to fibrosis (scarring) of the lung.
A new survey conducted during the pandemic by researchers at the Johns Hopkins Bloomberg School of Public Health and the SNF Agora Institute at Johns Hopkins University found a more-than-threefold increase in the percentage of U.S. adults who reported symptoms of psychological distress-from 3.9 percent in 2018 to 13.6 percent in April 2020.
The New York Times reports that "more than four decades after the surgeon general declared smoking a health hazard, the Senate on Thursday cleared the final hurdle to empowering federal officials to regulate cigarettes and other forms of tobacco for the first time.
Sequenom, Inc., a life sciences company providing innovative genetic analysis solutions, today announced the launch of its iPLEX ADME PGx panel developed to genotype polymorphisms in genes associated with drug absorption, distribution, metabolism, and excretion (ADME).
› Verified 1 days ago
| Entity Name | Sutter Bay Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013950807 PECOS PAC ID: 4284538778 Enrollment ID: O20031125000909 |
News Archive
Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and fibrotic organ failure, announced today that its lead clinical candidate STX-100 has been granted orphan drug status by the U.S. Food and Drug Administration for the treatment of idiopathic pulmonary fibrosis, a debilitating and almost uniformly fatal disease in which patients experience progressive difficulty breathing due to fibrosis (scarring) of the lung.
A new survey conducted during the pandemic by researchers at the Johns Hopkins Bloomberg School of Public Health and the SNF Agora Institute at Johns Hopkins University found a more-than-threefold increase in the percentage of U.S. adults who reported symptoms of psychological distress-from 3.9 percent in 2018 to 13.6 percent in April 2020.
The New York Times reports that "more than four decades after the surgeon general declared smoking a health hazard, the Senate on Thursday cleared the final hurdle to empowering federal officials to regulate cigarettes and other forms of tobacco for the first time.
Sequenom, Inc., a life sciences company providing innovative genetic analysis solutions, today announced the launch of its iPLEX ADME PGx panel developed to genotype polymorphisms in genes associated with drug absorption, distribution, metabolism, and excretion (ADME).
› Verified 1 days ago
| Entity Name | County Of Santa Clara |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699885079 PECOS PAC ID: 1254244973 Enrollment ID: O20040113000784 |
News Archive
Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and fibrotic organ failure, announced today that its lead clinical candidate STX-100 has been granted orphan drug status by the U.S. Food and Drug Administration for the treatment of idiopathic pulmonary fibrosis, a debilitating and almost uniformly fatal disease in which patients experience progressive difficulty breathing due to fibrosis (scarring) of the lung.
A new survey conducted during the pandemic by researchers at the Johns Hopkins Bloomberg School of Public Health and the SNF Agora Institute at Johns Hopkins University found a more-than-threefold increase in the percentage of U.S. adults who reported symptoms of psychological distress-from 3.9 percent in 2018 to 13.6 percent in April 2020.
The New York Times reports that "more than four decades after the surgeon general declared smoking a health hazard, the Senate on Thursday cleared the final hurdle to empowering federal officials to regulate cigarettes and other forms of tobacco for the first time.
Sequenom, Inc., a life sciences company providing innovative genetic analysis solutions, today announced the launch of its iPLEX ADME PGx panel developed to genotype polymorphisms in genes associated with drug absorption, distribution, metabolism, and excretion (ADME).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tyler Francis Aguinaldo, MD 325 Distel Cir, Los Altos, CA 94022-1408 Ph: (650) 652-8282 | Tyler Francis Aguinaldo, MD 1501 Trousdale Dr Fl 3, Burlingame, CA 94010-4506 Ph: (650) 652-8580 |
News Archive
Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and fibrotic organ failure, announced today that its lead clinical candidate STX-100 has been granted orphan drug status by the U.S. Food and Drug Administration for the treatment of idiopathic pulmonary fibrosis, a debilitating and almost uniformly fatal disease in which patients experience progressive difficulty breathing due to fibrosis (scarring) of the lung.
A new survey conducted during the pandemic by researchers at the Johns Hopkins Bloomberg School of Public Health and the SNF Agora Institute at Johns Hopkins University found a more-than-threefold increase in the percentage of U.S. adults who reported symptoms of psychological distress-from 3.9 percent in 2018 to 13.6 percent in April 2020.
The New York Times reports that "more than four decades after the surgeon general declared smoking a health hazard, the Senate on Thursday cleared the final hurdle to empowering federal officials to regulate cigarettes and other forms of tobacco for the first time.
Sequenom, Inc., a life sciences company providing innovative genetic analysis solutions, today announced the launch of its iPLEX ADME PGx panel developed to genotype polymorphisms in genes associated with drug absorption, distribution, metabolism, and excretion (ADME).
› Verified 1 days ago
Dr. Jane I Huang, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1501 Trousdale Dr, Burlingame, CA 94010 Phone: 650-696-5400 | |
Richard C Liu, D.O. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1501 Trousdale Dr, Burlingame, CA 94010 Phone: 650-458-0032 | |
Dr. Sami H Bogale, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1501 Trousdale Dr, Burlingame, CA 94010 Phone: 650-696-5400 | |
Tak Poon, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1501 Trousdale Dr, 2nd Floor, Burlingame, CA 94010 Phone: 650-652-8600 | |
Dr. Amir Ali Schricker, M.D Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1501 Trousdale Dr, Burlingame, CA 94010 Phone: 650-652-8600 | |
Kevin Kin Chiu Yuen, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1501 Trousdale Dr, Burlingame, CA 94010 Phone: 650-389-9800 | |
Dr. Chhavi Mehta, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1501 Trousdale Drive, 3rd Floor, Burlingame, CA 94010 Phone: 650-652-8500 Fax: 650-652-8501 |